Table 1 Demographic and clinical characteristics of the studied sample
Variables | Li-R (n = 15) | Li-NR (n = 14) | p (Li-R vs. Li-NR) | BD (n = 29) | HC (n = 15) | p (BD vs HC) |
|---|---|---|---|---|---|---|
Age (mean ± SD) | 42.7 ± 15.6 | 42.9 ± 12.9 | 0.97 | 42.8 ± 14.1 | 42.4 ± 5.1 | 0.89 |
Sex (M/F) | 7/8 | 7/7 | 1 | 14/15 | 7/8 | 1 |
Age at onset (mean ± SD) | 27.7 ± 13.7 | 25.1 ± 7.9 | 0.54 | / | ||
Years of illness (mean ± SD) | 14.7 ± 7.4 | 13.3 ± 9.9 | 0.66 | / | ||
Years of lithium (mean ± SD) | 7.4 ± 7.7 | 10.4 ± 5.1 | 0.24 | / | ||
TS of the Alda scale (mean ± SD) | 8.6 ± 0.91 | 0.00 ± 0.00 | / | / | ||
Number of episodes (mean ± SD) | 6.5 ± 4.5 | 13.3 ± 5.9 | 0.002 | / | ||
Psychotic symptoms (Y/N) | 6/9 | 11/3 | 0.06* | / | ||
Suicide attempts (Y/N) | 1/14 | 6/8 | 0.03* | / |